Skip to main content
Search
Newsletters
Watchlist
Home
Watchlist
For You
Canada
World
Business
Investing
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Latest in
TSX Today:
MFC-T
+1.15%
WEED-T
+11.22%
ENB-T
-0.54%
TLRY-T
+3.2%
SU-T
+1.06%
HNU-T
+4.63%
CVE-T
-0.4%
Search stocks, ETFs and Commodities
Instrument Name
Adicet Bio Inc
Instrument Symbol
(ACET-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
Pre Market
Change
Pre Market
Last Update
Pre Market
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Adicet Bio Inc
131 DARTMOUTH STREET 3RD FLOOR
BOSTON MA 02116 USA
P:
650-503-9095
http://www.adicetbio.com
Sectors & Indices
Sector
Industry
Employees
SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Indices Russell 2000
Indices Russell 3000
Profile
Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.
Key Executives
Name
Title
Chen Schor
CEO/Director/President
Nick Harvey
CFO/Chief Accounting Officer
More from The Globe
number cruncher
U.S technology stocks with earnings and price momentum
Yesterday
Lightspeed Commerce stock soars on better-than-expected profit forecast
Yesterday
GameStop, AMC continue to slide as meme stocks rally loses steam
Yesterday
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
Yesterday
Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
May 15, 2024
The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
May 15, 2024
Chevron tops Tesla as most-shorted stock in April, says Hazeltree
May 14, 2024
The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
May 14, 2024